NYSE: PHGKoninklijke Philips Nv Stock
$18.35+0.44 (+2.46%)
Updated Mar 31, 2023
PHG Price
$18.35
Fair Value Price
N/A
Market Cap
$16.18B
52 Week Low
$11.75
52 Week High
$31.53
P/E
-9.38x
P/B
1.14x
P/S
0.69x
PEG
N/A
Dividend Yield
5.25%
Revenue
$19.17B
Earnings
-$1.71B
Gross Margin
40.4%
Operating Margin
-8.21%
Profit Margin
-9%
Debt to Equity
1.31
Operating Cash Flow
-$184M
Beta
0.88
Next Earnings
Apr 24, 2023
Ex-Dividend
N/A
Next Dividend
N/A
PHG Overview
Koninklijke Philips N.V. develops and manufactures medical systems (diagnostic imaging, enterprise diagnostic informatics, image-guided therapy, ultrasound, monitoring and analytics, sleep and respiratory care, population health management, and connected care informatics and therapeutic care products). It also offers baby care products (baby bottles, sterilizers, etc.), personal care products (brush heads, shavers, groomers, trimmers, skin care, hair care and hair removal), oral healthcare products (power toothbrushes), and consumer electronics products. Koninklijke Philips was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Zen Score
–
Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PHG scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PHG is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PHG is good value based on its book value relative to its share price (1.14x), compared to the US Diagnostics & Research industry average (4.28x)
P/B vs Industry Valuation
PHG is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more PHG due diligence checks available for Premium users.
Be the first to know about important PHG news, forecast changes, insider trades & much more!
PHG News
Valuation
PHG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-9.38x
Industry
33.78x
Market
22.13x
PHG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.14x
Industry
4.28x
PHG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PHG's financial health
Profit margin
Revenue
$19.0B
Net Income
-$1.7B
Profit Margin
-9%
PHG's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PHG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$32.6B
Liabilities
$18.5B
Debt to equity
1.31
PHG's short-term assets ($11.03B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PHG's short-term assets ($11.03B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PHG's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
PHG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$184.0M
Investing
-$1.6B
Financing
$531.9M
PHG's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PHG vs Diagnostic & Research Stocks
Koninklijke Philips Nv Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.